Home

Eli Lilly and Company - Financial Overview

Ticker - LLY

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$769.88$691.15B62.434.024.6%17.5%46.3

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $24.5B $6.2B $6.47 N/A N/A N/A
1 2021-12-31 $28.3B $5.6B $5.85 15.4% -9.9% -9.6%
2 2022-12-31 $28.5B $6.2B $6.57 0.8% 11.9% 12.3%
3 2023-12-31 $34.1B $5.2B $5.82 19.6% -16.1% -11.4%
4 2024-12-31 $45.0B $10.6B $11.76 32.0% 102.1% 102.1%
5 TTM 2025-03-31 $49.0B $11.1B $12.31 8.8% 4.9% 4.7%
6 Average 15.3% 18.6% 19.6%




LLY - Forecast Data



LLY - Y/Y % Change

  Metric Value
0 Total Assets $89,389M
1 Cash $3,093M
2 Total Liabilities $73,542M
3 Total Debt $38,516M
4 Total Equity $15,765M
5 Debt to Equity Ratio 2.44
LLY Balance Sheet Chart


LLY - Expense Overview



LLY - Unmapped Expense Line Items

No unmapped expenses.



LLY - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$769.88 4.5% Nicks Growth: N/A
Nick's Expected Margin: N/A
FINVIZ Growth: 41%
Nicks: 6
Finviz: 231
Nick's: 0.000 14.1 62.4
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$12.31 EPS TTM $77.60 -89.9% $2,848.46 270.0%
$21.95 EPS 2025 $138.36 -82.0% $5,079.09 559.7%
$30.77 EPS 2026 $193.96 -74.8% $7,119.99 824.8%